tetrazomine: from actinomycete strain Y-09194L; MF C24-H35-N4-O5; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 188405 |
| MeSH ID | M0189980 |
| Synonym |
|---|
| tetrazomine |
| 132073-72-4 |
| 2-piperidinecarboxamide, 3-hydroxy-n-(2a,3,4,5,6,6a,7,11b-octahydro-5-(hydroxymethyl)-11-methoxy-12-methyl-3,6-imino-1h-2-oxa-11c-azanaphth(1,2,3-cd)azulen-10-yl)- |
| 3-hydroxy-n-[5-(hydroxymethyl)-11-methoxy-12-methyl-2a,3,4,5,6,6a,7,11b-octahydro-1h-3,6-epimino-2-oxa-11c-azanaphtho[1,2,3-cd]azulen-10-yl]piperidine-2-carboximidic acid |
| DTXSID60927522 |
| (3r)-3-hydroxy-n-[(1s,2s,3r,5r,6r,9r)-3-(hydroxymethyl)-11-methoxy-18-methyl-7-oxa-17,18-diazapentacyclo[7.7.1.12,5.06,17.010,15]octadeca-10(15),11,13-trien-12-yl]piperidine-2-carboxamide |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||